Scott N. Boyle

Chief Business Officer at C4 Therapeutics · 5 reported transactions in 1 company · latest report Feb 14, 2026

Their trades


C4 TherapeuticsCCCC	Shares withheld for tax $13.7K · 7,269 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Exercised options — · 20,950 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Shares withheld for tax $3.3K · 1,735 shares	Feb 13, 2026
C4 TherapeuticsCCCC	Exercised options — · 5,000 shares	Feb 13, 2026
C4 TherapeuticsCCCC	Share award — · 200,000 shares	Feb 13, 2026

Shares withheld for taxC4 Therapeutics

Feb 14, 2026 · CCCC

$13.7K

Exercised optionsC4 Therapeutics

Feb 14, 2026 · CCCC

20,950

Shares withheld for taxC4 Therapeutics

Feb 13, 2026 · CCCC

$3.3K

Exercised optionsC4 Therapeutics

Feb 13, 2026 · CCCC

5,000

Feb 13, 2026 · CCCC

200,000

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Business Officer at C4 Therapeutics · 5 reported transactions in 1 company · latest report Feb 14, 2026


C4 TherapeuticsCCCC	Shares withheld for tax $13.7K · 7,269 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Exercised options — · 20,950 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Shares withheld for tax $3.3K · 1,735 shares	Feb 13, 2026
C4 TherapeuticsCCCC	Exercised options — · 5,000 shares	Feb 13, 2026
C4 TherapeuticsCCCC	Share award — · 200,000 shares	Feb 13, 2026

Shares withheld for taxC4 Therapeutics

Feb 14, 2026 · CCCC

$13.7K

Exercised optionsC4 Therapeutics

Feb 14, 2026 · CCCC

20,950

Shares withheld for taxC4 Therapeutics

Feb 13, 2026 · CCCC

$3.3K

Exercised optionsC4 Therapeutics

Feb 13, 2026 · CCCC

5,000

Feb 13, 2026 · CCCC

200,000

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.